HeartBeam seeks US FDA approval for its HeartBeam AIMIGo VECG System
HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D vector electrocardiogram (VECG) platform intended for patient use at home, announced it has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its HeartBeam AIMIGo System.
HeartBeam has developed the HeartBeam AIMIGo System, a personal, portable and easy-to-use VECG solution to assist patients and their clinicians in assessing cardiac symptoms. HeartBeam
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!